Download App

Log in to access Online Inquiry
Company Overview More
Fonda Holdings is a contract research organization (CRO) that provides comprehensive and scientific research, analysis and development services to pharmaceutical companies throughout the drug discovery and development process. Its departments include North America and China. The North American division includes laboratory testing, chemistry, manufacturing and control (CMC), preclinical research and chemical services in the United States and Canada. The Chinese department includes laboratory testing, CMC, preclinical research, bioequivalent clinical and chemical services in China. Its preclinical studies include drug metabolism and pharmacokinetics (DMPK), safety, chemistry and toxicology, as well as laboratory tests, including bioanalysis and biological preparations, as well as central laboratories. Its services and solutions include candidate drug evaluation, product development, clinical services, and central laboratory and testing services.
CEO: Song Li
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

01521 Frontage Holdings Corporation
2.720+0.140+5.43%
YOY
Do not show
Hide blank lines
(Q3)2022/03/31(FY)2021/12/31(Q6)2021/06/30(FY)2020/12/31
Assets
Current assets
Inventory
-- -- 30.66% 946K 367.21% 855K 318.5% 724K
Accounts receivable
-- -- 56.12% 42.54M 48.73% 36.08M 9.32% 27.25M
Withholding and tax receivable
-- -- 26.65% 5.23M 9.43% 4.45M 220.98% 4.13M
Cash and equivalents
-- -- -31.81% 144.63M -14.59% 182.61M 2.09% 212.09M
Secured deposit
-- -- 16687.5% 1.34M 1937.5% 163K -98.21% 8K
Other current assets
-- -- 58.98% 12.3M 31.94% 9.98M -1.09% 7.74M
Special items of current assets
-- -- 66.31% 4.08M -- 9.29M -- 2.45M
Total current assets
-- -- -17.03% 211.07M -2.58% 243.43M 4.94% 254.39M
Non-current assets
Property, plant and equipment
-- -- 113.72% 90.72M 110.48% 65.42M 50.21% 42.45M
Associated company interest
-- -- 1029.39% 5.34M -- -- -12.57% 473K
Secured deposits-non-current assets
-- -- 0% 300K -- 300K -- 300K
Financial assets at fair value-non-current assets
-- -- -- 1.57M -- 1.55M -- --
Intangible assets
-- -- 114.24% 31.69M 93.45% 14.11M 95.13% 14.79M
Goodwill
-- -- 186.88% 71.45M 228.49% 25.22M 298.51% 24.91M
Deferred tax assets
-- -- 48.45% 7.65M 77.56% 11.12M -38.07% 5.15M
Other illiquid assets
-- -- -- 94K -- 3.47M -- --
Special items of non-current assets
-- -- 39.01% 55.96M 11.92% 43.98M 84.62% 40.25M
Total non-current assets
-- -- 106.33% 264.77M 79.26% 165.17M 76.13% 128.33M
Total assets
-- -- 24.33% 475.84M 19.47% 408.6M 21.39% 382.71M
Liabilities
Current liabilities
Accounts payable
-- -- 89.46% 37.48M 81.88% 18.54M 90.33% 19.78M
Tax payable
-- -- 76.69% 4.37M 60.21% 2.69M 82.66% 2.48M
Amounts payable to associated parties-current liabilities
-- -- 0% 210K 0% 210K 0% 210K
Bank loans and overdrafts
-- -- -- 11K -- -- -- --
Financial lease liabilities-current liabilities
-- -- 40.42% 7.29M 35.63% 5.87M 37.58% 5.19M
Special items of current liabilities
-- -- 32.24% 23.63M 38.8% 21.39M 39.12% 17.87M
Total current liabilities
-- -- 60.33% 72.99M 53.04% 48.7M 56.58% 45.53M
Net current assets
-- -- -33.89% 138.08M -10.7% 194.73M -2.1% 208.86M
Total assets less current liabilities
-- -- 19.47% 402.85M 16.02% 359.9M 17.82% 337.19M
Non-current liabilities
Financial lease liabilities-non-current liabilities
-- -- 42.67% 50.55M 15.42% 39.3M 113.07% 35.43M
Deferred tax liability
-- -- 263.42% 11.2M 152% 3.02M 126.71% 3.08M
Other non-current liabilities
-- -- 83.8% 18.02M 210.57% 6.44M 235.03% 9.8M
Total non-current liabilities
-- -- 65.09% 79.77M 30.64% 48.76M 131.02% 48.32M
Total liabilities
-- -- 62.78% 152.76M 40.95% 97.46M 87.72% 93.84M
Total assets less total liabilities
-- 330.1M 11.84% 323.08M 14.03% 311.14M 8.89% 288.87M
Total equity and non-current liabilities
-- -- 19.47% 402.85M 16.02% 359.9M 17.82% 337.19M
Equity
Share capital
-- -- 0% 20K 0% 20K 0% 20K
Reserve
-- -- 11.11% 319.82M 13.88% 309.89M 8.8% 287.85M
Legal reserve
-- -- 11.11% 319.82M 13.88% 309.89M 8.8% 287.85M
Shareholders' Equity
-- -- 11.11% 319.84M 13.88% 309.91M 8.79% 287.87M
Non-controlling interest
-- -- 223.23% 3.24M 70.25% 1.24M 47.72% 1M
Total equity
-- -- 11.84% 323.08M 14.03% 311.14M 8.89% 288.87M
Total equity and total liabilities
-- -- 24.33% 475.84M 19.47% 408.6M 21.39% 382.71M
Currency Unit
USDUSDUSDUSD
Accounting Standards
IASIASIASIAS
Audit Opinions
--Unqualified Opinion--Unqualified Opinion
Auditor
--Hong Kong Lixin Dehao Accounting firm Co., Ltd.--Hong Kong Lixin Dehao Accounting firm Co., Ltd.

Q6, Q9, and FY are cumulative quarterly reports: Q6 is the interim report; Q9 is third quarter report; FY is the annual report.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%